Clinical trial
A Glucose Clamp Trial Investigating the Biosimilarity of Gan & Lee Insulin Glargine Injection (Insulin Glargine 100 U/mL) With US and EU Lantus® Comparator Products in Patients With Type 1 Diabetes Mellitus
NCT04236895 is registered in ClinicalTrials.gov with Gan and Lee Pharmaceuticals, USA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Glucose Clamp Trial Investigating the Biosimilarity of Gan & Lee Insulin Glargine Injection (Insulin Glargine 100 U/mL) With US and EU Lantus® Comparator Products in Patients With Type 1 Diabetes Mellitus
- Lead sponsor
- Gan and Lee Pharmaceuticals, USA
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 10, 2018
- Completion date
- November 28, 2018
- Enrollment
- 114 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.